中國創意(08368.HK)附屬與束彩文化就建立藝人個人官網訂合作框架協議
中國創意控股(08368.HK)公佈,於今日(4日),公司間接非全資附屬北京易聚與北京束彩文化訂立一份合作框架協議,內容有關雙方潛在合作。根據該合作框架協議,北京易聚與束彩同意同由北京易聚擁有的名爲「Aiwoo」的個人專屬移動社交網絡平臺合作,爲束彩旗下獨家簽約的逾三十位藝人建立和運營藝人個人專屬官網。合作框架協議有效期爲五年。
束彩主要在中國從事藝人經紀和管理服務。束彩旗下籤約有逾三十位藝人,包括影視劇演員,歌手,偶像型藝人和運動員等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.